IRCCS Ospedale Sacro Cuore Don Calabria

At IRCCS Ospedale Sacro Cuore Don Calabria, clinical trials in digestive system diseases focus on ulcerative colitis, a chronic inflammatory condition of the bowel. The studies are designed to assess whether new treatments can better control symptoms, improve endoscopic findings, and support lasting remission.

• Testing new therapies for moderately to severely active ulcerative colitis
• Evaluating treatment effectiveness for clinical remission and symptom relief
• Exploring longer-term benefits in ulcerative colitis care

These studies aim to expand options for patients who need more effective and durable control of intestinal inflammation.

Research in neoplasms at this site includes trials in prostate cancer, especially high-risk localized or locally advanced disease and oligometastatic prostate cancer. The main goal is to determine whether new treatment approaches can improve disease control and delay progression.

• Assessing therapies for high-risk localized prostate cancer
• Studying treatment strategies for oligometastatic prostate cancer
• Measuring outcomes such as metastasis-free survival and recurrence delay

These trials combine oncology expertise with a focus on improving long-term outcomes for men facing aggressive or early spread of prostate cancer.

The site is also active in cardiovascular diseases, with trials centered on preventing another ischemic stroke after a recent event or a high-risk transient ischemic attack. The research is evaluating whether newer antithrombotic approaches can lower the risk of recurrent stroke while maintaining safety.

• Preventing recurrent ischemic stroke after acute events
• Studying patients with high-risk transient ischemic attack
• Balancing stroke reduction with bleeding safety

These studies are important for refining secondary prevention strategies in patients at elevated risk of future vascular events.